SHOW TUTORIAL VIDEOShow Search Tutorial Video
(requires Flash, opens in new window) Show Tutorial VideoShow Search Tutorial Video
(requires Flash, opens in new window)
Product Details

anti-CEACAM5 (CEA, CD66e) antibody

Overview

Image for anti-CEACAM5 (CEA, CD66e) antibody
Antigen: CEACAM5 (CEA, CD66e)
Clonality: Monoclonal (26-3-13)
Application: Flow Cytometry (FACS), Cell-ELISA (cELISA), Immunohistochemistry (IHC), ELISA, Western Blotting (WB)
Reactivity: Human
Host: Mouse
9 references available 9 references available
Quantity: 100 ug (1mg/ml)
Price: 551,31 $   (Plus shipping costs $25 and VAT, Invoice in EUR)
Order number: ABIN108727
Availability: Ships within 1 to 2 Business days
Hints on ordering Hints on ordering
Add to basket

on this page

Additional Information
Application Details
Publications
Images
Related Products
Protocols

Customer Service

Technical Inquiry
Send product details to colleague
Download Datasheet

Additional Information  » anti-CEACAM5 (CEA, CD66e) antibody

back to top ^


Antigen CEACAM5 (CEA, CD66e)
Immunogen Immunisation with extracted protein of CEACAM5
Reactivity Human
Clonality Monoclonal
Format Purified
Isotype IgG1 »Matching secondary antibodies
Description CEACAM5 (CEA-related cell adhesion molecule 5, CEA) belongs to the carcinoembryonic antigen (CEA) gene family (5). It encodes a glycosyl phosphatidylinositol (GPI)- linked glycoprotein with a Mr of 180,000-200,000 which is most strongly expressed on epithelial cells of the fetal and adult colon and to a minor extent on epithelial cells of the stomach and sweat glands, squamous epithelial cell of the tongue, esophagus and cervix. CEACAM5 is used as a tumor marker for early detection of recurrent disease due its expression in adenocarcinomas of the colon, lung, breast, stomach and pancreas and in mucinous ovarian carcinomas (5). Like all members of the CEACAM family, it consists of a single N domain, with structural homology to the immunoglobulin variable domains, followed by six immunoglobulin constant-like A (A1, A2, A3) and B domains (B1, B2, B3).
Clone 26-3-13
Host Mouse
Specificity Anti-human CEACAM5 (CEA, CD66e)

Application Details  » anti-CEACAM5 (CEA, CD66e) antibody

back to top ^


Application Flow Cytometry (FACS), Cell-ELISA (cELISA), Immunohistochemistry (IHC), ELISA, Western Blotting (WB)
» Click here to view 9 available protocols!
Application Notes Flow cytometry: 1.2 ug/10^6 cells. ELISA: 1:200 - 1:400 CELISA: 1:200. Western blot: 4ug/ml. Immunohistology: 1-2 ug/10^6 cells (on cryosections)
Concentration 1mg/ml
Purification Protein G
Buffer Phosphate buffered saline, pH 7.2
Storage Short term: 2°C - 8°C. Long term: -20°C (avoid repeated freezing and thawing)
Research Area Receptors, Cancer, Receptors, Cell/Tissue Markers, Cancer
Restrictions For Research Use only

Publications  » anti-CEACAM5 (CEA, CD66e) antibody

back to top ^


Publications Strobel, Strobel, Bross et al.: "Effects of human bone marrow stroma on the growth of human tumor cells." In: Cancer research , Vol. 49, Issue 4, pp. 1001-7, 1989 (PubMed)

Grunert, AbuHarfeil, Schwarz et al.: "Two CEA and three NCA species, although distinguishable by monoclonal antibodies, have nearly identical peptide patterns." In: International journal of cancer. Journal international du cancer , Vol. 36, Issue 3, pp. 357-62, 1985 (PubMed)

Thompson, Moessinger, Reichardt et al.: "A polymerase-chain-reaction assay for the specific identification of transcripts encoded by individual carcinoembryonic antigen (CEA)-gene-family members." In: International journal of cancer. Journal international du cancer , Vol. 55, Issue 2, pp. 311-9, 1993 (PubMed)

Krop-Watorek, Laskowska, Salwa et al.: "CEA-related proteins on human urothelial cell lines of different transformation grades." In: Cancer letters , Vol. 139, Issue 1, pp. 15-22, 1999 (PubMed)

Schoelzel, Zimmermann, Schwarzkopf et al.: "Carcinoembryonic antigen family members CEACAM6 and CEACAM7 are differentially expressed in normal tissues and oppositely deregulated in hyperplastic colorectal polyps and early adenomas." In: The American journal of pathology , Vol. 156, Issue 2, pp. 595-605, 2000 (PubMed)

Baczy?ska, Wietrzyk, Madej et al.: "The tumorigenic potential of human CX-1 colon adenocarcinoma cells depends on carcinoembryonic antigen (CEACAM5) expression." In: Cellular & molecular biology letters , Vol. 8, Issue 2, pp. 471-86, 2003 (PubMed)

Schmitter, Agerer, Peterson et al.: "Granulocyte CEACAM3 is a phagocytic receptor of the innate immune system that mediates recognition and elimination of human-specific pathogens." In: The Journal of experimental medicine , Vol. 199, Issue 1, pp. 35-46, 2004 (PubMed)

Kammerer, Riesenberg, Weiler et al.: "The tumour suppressor gene CEACAM1 is completely but reversibly downregulated in renal cell carcinoma." In: The Journal of pathology , Vol. 204, Issue 3, pp. 258-67, 2004 (PubMed)

Noeckel, van den Engel, Winter et al.: "Characterization of gastric adenocarcinoma cell lines established from CEA424/SV40 T antigen-transgenic mice with or without a human CEA transgene." In: BMC cancer , Vol. 6, pp. 57, 2006 (PubMed)